Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

arzoxifene hydrochloride

Known as: 2-(4-Methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]benzo[b]thiophene-6-ol hydrochloride, Arzoxifene.HCl, Arzoxifenehydrochloride 
The hydrochloride salt of arzoxifene, a synthetic aromatic derivative with anti-estrogenic properties. Arzoxifene binds to estrogen receptors as a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Development of the arzoxifene hydrochloride drug substance manufacturing process, first via a traditional approach and… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2011
2011
There is association between exposure to estrogens and the development and progression of hormone-dependent gynecological cancers… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2007
2007
Long-term usage of the selective estrogen receptor modulator (SERM) tamoxifen has been associated with an increased risk of… Expand
Is this relevant?
2006
2006
PURPOSE We tested whether a selective estrogen receptor modulator (SERM) and a rexinoid are active for prevention and treatment… Expand
Is this relevant?
2005
2005
Although selective estrogen receptor modulators (SERMs) are useful in the treatment and prevention of breast cancer, the SERM… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 7
Is this relevant?
2004
2004
The benzothiophene arzoxifene is a new 3rd generation selective estrogen receptor (ER) modulator (SERM). We have investigated the… Expand
Is this relevant?
Review
2003
Review
2003
Arzoxifene is a benzothiophene second-generation selective estrogen receptor modulator (SERM) under development by Eli Lilly & Co… Expand
Is this relevant?
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
Review
2001
Review
2001
The agents used for endocrine therapy in patients with breast cancer have changed markedly over the past decade. Tamoxifen… Expand
Is this relevant?